Results 261 to 270 of about 14,806,844 (291)

Contezolid in tuberculous meningitis: comparable efficacy and favorable safety. [PDF]

Front Cell Infect Microbiol
Liao Y, Lv F, Quan T, Zheng L, Wu G.
europepmc   +1 more source

Early outcomes of South African children with persistent viral non-suppression following switch to dolutegravir-based antiretroviral therapy. [PDF]

South Afr J HIV Med
Guerrini M, Maré M, Hulsman C, Greybe L, Lishman J, Edson C, Hisham T, Frigati L, Rabie H.   +8 more
europepmc   +1 more source

Rapid Diagnostics and Rapid Antimicrobial Susceptibility Testing for Bloodstream Infections: A Narrative Review and Proposed Clinical Actionability Framework. [PDF]

Int J Gen Med
Chen Q, Qu YG, Li JS, Yan J.
europepmc   +1 more source

Performance of next-generation sequencing technologies for detecting drug-resistant tuberculosis in people with pulmonary tuberculosis. [PDF]

Cochrane Database Syst Rev
Durairaj E, Rajbongshi J, Vincent M.
europepmc   +1 more source

Characteristics of Primary and acquired multidrug-resistant tuberculosis patients in West Java, Indonesia. [PDF]

IJID Reg
Santoso P, Khairani AP, Buchori E, Chaidir L, Soeroto AY.   +4 more
europepmc   +1 more source

Changes of bladder urodynamics after combined pelvic floor muscle training and intravaginal stimulation in women with stress urinary incontinence: a retrospective cohort study. [PDF]

Front Bioeng Biotechnol
Lau HH, Lai CY, Hsieh MC, Peng HY, Chou D, Su TH, Lee JJ, Lin TB.   +7 more
europepmc   +1 more source

Circulating pre-treatment and acquired HIV drug resistance Mutations in Dar es Salaam, Tanzania

Circulating pre-treatment and acquired HIV drug resistance Mutations in Dar es Salaam, Tanzania
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China

HIV Medicine, 2022
AbstractObjectivesThis study investigated the prevalence and patterns of pre‐treatment and acquired HIV drug resistance mutations among people living with HIV (PLWH) on antiretroviral therapy (ART) for 12 (±3) months in Tianjin, China.MethodsFrom Jan 2018 to Dec 2020, PLWH with HIV‐1 RNA greater than 1000 copies/mL visiting the ART clinic in the ...
Silvere D Zaongo
exaly   +3 more sources

The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017–2018 [PDF]

Journal of the International AIDS Society, 2022
AbstractIntroductionMonitoring the population‐level emergence and transmission of HIV drug resistance (HIVDR) is necessary for supporting public health programmes. This study provides a nationally representative prevalence estimate of HIVDR in people initiating antiretroviral therapy (ART) and estimates of acquired HIVDR and viral load (VL) suppression
Thi Thuy Van Nguyen, Vu Quoc Dat, Natalie E. Dean   +2 more
exaly   +3 more sources

Prevalence of HIV-1 pre-treatment drug resistance in a southern province of Iran, 2016-2017

Archives of Virology, 2017
HIV-1 transmitted drug resistance (TDR) occurs when primary viruses bear drug resistance mutations (DRMs). TDR causes first-line antiretroviral (ARV) therapy (ART) failure and is becoming more pronounced due to the widespread use of ART. With the absence of routine individual-level drug resistance testing, the World Health Organization (WHO) recommends
Arash, Memarnejadian, Hamed, Gouklani, Samira, Mohammadi, Masoomeh, Moosazadeh, Joshua, Choi   +4 more
openaire   +2 more sources